glp 1 discovery GLP-1-based therapies for diabetes, obesity and beyond Historical timeline of GLP-1 biology,
Description
Le Roux, C
28 The effect of weight loss through these recently approved, but increasingly used, drugs on nephrolithiasis risk in patients with known stone disease is not well understood
What the drug does for a person taking it purely for weight loss, with no such history, is a related but separate question one on which the evidence is thinner
Most show long-term benefits with manageable risks
2022 doi: 10.1056/NEJMoa2208601
Consider this a clinician-style shortlist of types that are commonly used in research and real-world GI care
